These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3791770

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Scientific overview of multiple sclerosis.
    Walker JE.
    Prog Clin Biol Res; 1982; 106():233-7. PubMed ID: 6757942
    [No Abstract] [Full Text] [Related]

  • 3. [Plasmapheresis in the treatment of neurologic disorders].
    Szobor A, Fornádi L, Vájlok M.
    Orv Hetil; 1988 Jan 17; 129(3):119-23. PubMed ID: 3281091
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S, Hohlfeld R.
    Nervenarzt; 1992 Feb 17; 63(2):116-9. PubMed ID: 1314334
    [No Abstract] [Full Text] [Related]

  • 6. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL, Fosburg M, Kevy S, Weiner HL.
    Prog Clin Biol Res; 1982 Feb 17; 106():239-54. PubMed ID: 6184727
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutic applications of hemapheresis].
    Huestis DW, Pineda AA.
    Sangre (Barc); 1982 Feb 17; 27(6):1059-72. PubMed ID: 6764036
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Multiple sclerosis: an update].
    Duquette P.
    Union Med Can; 1988 Aug 17; 118(3):231-5. PubMed ID: 3051618
    [No Abstract] [Full Text] [Related]

  • 13. Management of multiple sclerosis.
    Poser CM.
    Compr Ther; 1981 Apr 17; 7(4):53-9. PubMed ID: 6263543
    [No Abstract] [Full Text] [Related]

  • 14. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B, Sørensen PS.
    Ugeskr Laeger; 1994 Oct 24; 156(43):6353-8. PubMed ID: 7810008
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic studies on leukapheresis and plasmapheresis.
    Hill N.
    Prog Clin Biol Res; 1981 Oct 24; 65():147-54. PubMed ID: 7330069
    [No Abstract] [Full Text] [Related]

  • 16. Plasmapheresis in multiple sclerosis.
    McLeod BC.
    J Clin Apher; 2003 Oct 24; 18(2):72-4. PubMed ID: 12874820
    [No Abstract] [Full Text] [Related]

  • 17. [Acute and reversible worsening of multiple sclerosis treated with plasmapheresis. A form of Uhthoff symptom?].
    Muchnik S, Jáuregui WO, Mazía C.
    Medicina (B Aires); 1985 Oct 24; 45(2):207-8. PubMed ID: 3841931
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of lymphocytapheresis on multiple sclerosis].
    Munakata R, Utsugisawa K, Nagane Y, Ukitsu M, Tohgi H.
    No To Shinkei; 1999 Mar 24; 51(3):235-9. PubMed ID: 10226287
    [Abstract] [Full Text] [Related]

  • 19. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
    Tindall RS, Walker JE, Ehle AL, Near L, Rollins J, Becker D.
    Neurology; 1982 Jul 24; 32(7):739-43. PubMed ID: 7201110
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.